Chronic mucocutaneous candidiasis, from bench to bedside
- PMID: 20133219
- DOI: 10.1684/ejd.2010.0910
Chronic mucocutaneous candidiasis, from bench to bedside
Abstract
Chronic mucocutaneous candidiasis (CMC) defines a heterogeneous group of orphan and inherited syndromes characterised by chronic and recurrent infections of the skin and mucosa with the yeast Candida. Increasing evidence suggests that this inefficient defence against Candida species is reflected by a DC/T cell defect which results in an impaired Th17 and Th1 immune response and, consecutively, a failed immune instruction of tissue cells. Little is known about the incidence and prognosis of CMC. Clinically, the main complications are debilitating hands (Candida granuloma) and oesophageal stricture with potential mal-digestion/-absorption. Furthermore, the chronic infections are likely a risk factor for the development of squamous cell carcinoma. Since resistance to anti-mycotic drugs evolves rapidly, efficient and flexible therapeutic management is essential for CMC patients.
Similar articles
-
Altered, but not diminished specific T cell response in chronic mucocutaneous candidiasis patients.Arch Dermatol Res. 2007 Dec;299(10):475-81. doi: 10.1007/s00403-007-0792-3. Epub 2007 Oct 25. Arch Dermatol Res. 2007. PMID: 17960405
-
Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.J Allergy Clin Immunol. 2010 Nov;126(5):1006-15, 1015.e1-4. doi: 10.1016/j.jaci.2010.08.027. Epub 2010 Oct 8. J Allergy Clin Immunol. 2010. PMID: 20934207
-
Invariant natural killer T (iNKT) cell deficiency in chronic mucocutaneous candidiasis--a consequence or a cause?Immunol Lett. 2011 Mar 30;135(1-2):180-3. doi: 10.1016/j.imlet.2010.09.014. Epub 2010 Oct 12. Immunol Lett. 2011. PMID: 20923687
-
Chronic mucocutaneous candidiasis.Pediatr Infect Dis J. 2001 Feb;20(2):197-206. doi: 10.1097/00006454-200102000-00017. Pediatr Infect Dis J. 2001. PMID: 11224843 Review.
-
Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.Oral Dis. 2019 Apr;25(3):684-692. doi: 10.1111/odi.12881. Epub 2018 Jun 8. Oral Dis. 2019. PMID: 29702748 Review.
Cited by
-
Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED): A Comprehensive Review.Biomedicines. 2024 Jan 9;12(1):132. doi: 10.3390/biomedicines12010132. Biomedicines. 2024. PMID: 38255237 Free PMC article. Review.
-
Signaling pathways and targeted therapies for psoriasis.Signal Transduct Target Ther. 2023 Nov 27;8(1):437. doi: 10.1038/s41392-023-01655-6. Signal Transduct Target Ther. 2023. PMID: 38008779 Free PMC article. Review.
-
Analysis of a series of Italian APECED patients with autoimmune hepatitis and gastro-enteropathies.Front Immunol. 2023 Jun 30;14:1172369. doi: 10.3389/fimmu.2023.1172369. eCollection 2023. Front Immunol. 2023. PMID: 37457714 Free PMC article.
-
Single-cell RNA sequencing combined with whole exome sequencing reveals the landscape of the immune pathogenic response to chronic mucocutaneous candidiasis with STAT1 GOF mutation.Front Immunol. 2022 Sep 15;13:988766. doi: 10.3389/fimmu.2022.988766. eCollection 2022. Front Immunol. 2022. PMID: 36225936 Free PMC article. Review.
-
Case Report: Disseminated Talaromyces marneffei Infection in a Patient With Chronic Mucocutaneous Candidiasis and a Novel STAT1 Gain-of-Function Mutation.Front Immunol. 2021 Aug 5;12:682350. doi: 10.3389/fimmu.2021.682350. eCollection 2021. Front Immunol. 2021. PMID: 34421897 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
